FDA recall, , Moderate risk
ImpactLife PF24RT24 Plasma
PF24RT24 Plasma was distributed after incomplete donor screening.
Recall ended May 26, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
ImpactLife is recalling PF24RT24 Plasma because it was collected from a donor for whom donor eligibility screening was incomplete. The product was distributed in Missouri. The recall began on April 4, 2025, and was added to the FDA's Enforcement Report on May 26, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
PF24RT24 Plasma
Recall details
- Company began the recall
- Sold in
- Company
- ImpactLife
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98935
- Recall number
- B-0075-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
